Jazz Pharmaceuticals plc: BofA Global Research raises price objective to $313 from $307
JAZZ•BofA Global Research raised its price objective for Jazz Pharmaceuticals to $313 from $307.
Related News
Liquidia Corporation: BofA Global Research cuts price objective to $38 from $40
LQDA•
Capital Fund Management discloses net short position in Abivax shares
ABVX•
Nasdaq pauses trading in BMHL for volatility at 10:05 a.m.
BMHL•
Zedge names Morris Berger CEO effective Oct. 1, 2026
ZDGE•
Nasdaq trading pause at 10:41 a.m.
QETA•